You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 72 Issue 5

November 2011

Volume 72, Issue 5

Pages 727–868

  1. Viewpoint and commentaries

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe (pages 727–730)

      Atholl Johnston, Roland Asmar, Björn Dahlöf, Kate Hill, David Albert Jones, Jens Jordan, Michael Livingston, Graham MacGregor, Michael Sobanja, Panagiotis Stafylas, Enrico Agabiti Rosei and José Zamorano

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.03987.x

    2. You have free access to this content
      Generic substitution (pages 731–732)

      John Posner and John P. Griffin

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.03920.x

    3. You have free access to this content
  2. Reviews

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
      Medical management of paraquat ingestion (pages 745–757)

      Indika B. Gawarammana and Nicholas A. Buckley

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04026.x

  3. Pharmacokinetics

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal (pages 758–767)

      Denis Garot, Renaud Respaud, Philippe Lanotte, Nicolas Simon, Emmanuelle Mercier, Stephan Ehrmann, Dominique Perrotin, Pierre-François Dequin and Chantal Le Guellec

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04005.x

    2. You have free access to this content
      Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man (pages 768–774)

      Xin Liu, Jeff E. Grice, Juergen Lademann, Nina Otberg, Sindy Trauer, Alexa Patzelt and Michael S. Roberts

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04022.x

  4. Pharmacokinetic dynamic relationships

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase (pages 775–786)

      Nimish N. Vachharajani, Ralph H. Raymond, Wen-Chyi Shyu, Bruce C. Stouffer and David W. Boulton

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04003.x

    2. You have free access to this content
      Drug−disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity (pages 787–797)

      Forough Sanaee, John D. Clements, Alistair W. G. Waugh, Richard N. Fedorak, Richard Lewanczuk and Fakhreddin Jamali

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04019.x

  5. Drug interactions

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment (pages 798–805)

      Martina Teichert, Loes E. Visser, Andrė G. Uitterlinden, Albert Hofman, Peter J. Buhre, Sabine Straus, Peter A. G. M. De Smet and Bruno HCh Stricker

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04004.x

  6. Drug safety

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective (pages 806–822)

      Claire Anderson, Janet Krska, Elizabeth Murphy, Anthony Avery and on behalf of the Yellow Card Study Collaboration

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.03990.x

  7. Pharmacoepidemiology

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes (pages 823–831)

      Adeline Gallini, Blandine Juillard-Condat, Marie-Claude Saux and Florence Taboulet

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.03997.x

  8. Letters to the editors

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Effect of nicotine on cytochrome P450 1A2 activity (pages 836–838)

      Janne Hukkanen, Peyton Jacob III, Margaret Peng, Delia Dempsey and Neal L. Benowitz

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04023.x

    4. You have free access to this content
      QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus (pages 839–841)

      Emanuel Raschi, Elisabetta Poluzzi, Ariola Koci, Giuseppe Boriani and Fabrizio De Ponti

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04065.x

  9. Book review

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Stem cells in the respiratory system (page 842)

      Matthew Hind

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04028.x

  10. Abstracts

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of October 4, 2010 (pages 843–863)

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04014.x

      Corrected by:

      Erratum: Erratum

      Vol. 74, Issue 5, 902, Article first published online: 9 OCT 2012

  11. Mandarin translations section

    1. Top of page
    2. Viewpoint and commentaries
    3. Reviews
    4. Pharmacokinetics
    5. Pharmacokinetic dynamic relationships
    6. Drug interactions
    7. Drug safety
    8. Pharmacoepidemiology
    9. Letters to the editors
    10. Book review
    11. Abstracts
    12. Mandarin translations section
    1. You have free access to this content
      Translation Section (pages 864–868)

      Article first published online: 11 OCT 2011 | DOI: 10.1111/j.1365-2125.2011.04101.x

SEARCH

SEARCH BY CITATION